Indian J Pharm Close
 

Figure 1: Effect of scopolamine (SCO; 0.75, 1.5 and 3 mg/kg ip) on transfer latency time (TLT) in the PA test to observe the effect on (a) acquisition, administered 30 minutes prior to fi rst trial, (b) consolidation, administered 5 min prior to 1st trial and (c) recall, administered 30 minutes prior to second trial. The maximal time of latency was set at 270s (cutoff time). Values are expressed as mean ± SEM; n = fi ve. *P < 0.05, **P < 0.01 signifi cant increase in TLT on second trial as compared to their respective fi rst trial; student’s (paired) ‘t’ test.

Figure 1: Effect of scopolamine (SCO; 0.75, 1.5 and 3 mg/kg ip) on transfer latency time (TLT) in the PA test to observe the effect on (a) acquisition, administered 30 minutes prior to fi rst trial, (b) consolidation, administered 5 min prior to 1st trial and (c) recall, administered 30 minutes prior to second trial. The maximal time of latency was set at 270s (cutoff time). Values are expressed as mean ± SEM; n = fi ve. *P < 0.05, **P < 0.01 signifi cant increase in TLT on second trial as compared to their respective fi rst trial; student’s (paired) ‘t’ test.